LYUMJEV FDA approval date

The FDA approved LYUMJEV on 15 Jun 2020.

FDA approval date
15 Jun 2020

Drug identity has not yet been verified against registry records

Also recorded as INSULIN LISPRO-AABC

Included trials

No linked trials for this drug yet. Browse all trials

PDUFA dates and FDA decisions

Date as reportedDrug / companyEventConditionEvidence
2020-06-15DayLYUMJEVFDA original application approvalFDA approval decisionNot specifiedOpen original source
Read source excerpt

{"application_number": "BLA761109", "applicant_as_listed_by_fda": "ELI LILLY AND CO", "brand_names": ["LYUMJEV"], "active_ingredients": ["INSULIN LISPRO-AABC"], "submission_type": "ORIG", "submission_number": "1", "submission_status": "AP", "submission_status_date": "20200615", "matched_on": "drug record created from this FDA brand name"}

First seen: 06 Oct 2026 · Evidence last checked: 06 Oct 2026